Back to Search
Start Over
Preclinical data on Mdm2 antisense oligonucleotide published
- Source :
- Cancer Gene Therapy Week. Oct 27, 2003, p37
- Publication Year :
- 2003
-
Abstract
- 2003 OCT 27 - (NewsRx.com & NewsRx.net) -- Hybridon, Inc., (HYBN) announced the publication of a paper on an Mdm2 antisense oligonucleotide in models of human prostate cancer. The study [...]
- Subjects :
- Hybridon Inc.
Biotechnology industry
Subjects
Details
- Language :
- English
- ISSN :
- 15436829
- Database :
- Gale General OneFile
- Journal :
- Cancer Gene Therapy Week
- Publication Type :
- News
- Accession number :
- edsgcl.109222967